This supports the interpretation that these phytochemicals are not being artificially forced into an implausible flat surface but, instead, occupy a region with predicted small-molecule ligand ability at the RBD–ACE2 interface (Figure 2), potentially hindering the formation of the infection-initiating complex as a putative molecular mechanism that explains the ELISA immunoassays results. This evidence concerns the gene ACE2 and infection.